Frederic Ors

Frederic Ors appears in our data through filings on IMV Inc. (formerly Immunovaccine Inc.) shares, published by SEDI. We count 11 filings; the first trade dates from 2 May 2018 and the latest from 4 October 2019.

Every open-market trade on record is a purchase: 8 purchases worth €105k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise. In 2019 alone, the filings show 5 purchases and no sales.

A typical purchase (the median) is worth €13k. No cluster: in 8 purchases, no other insider of the company bought within 30 days.

Most recently, on 7 October 2019, the filings show an open-market purchase worth €13k in IMV Inc. (formerly Immunovaccine Inc.). The median gap between a trade and its publication by SEDI is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.